Quick Answer
Evogene Ltd. reported Total Assets of $20.05 million for fiscal year 2025.
Evogene Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $20.05M -49.7% |
$39.86M -22.0% |
$51.10M -9.0% |
$56.13M -26.4% |
$76.30M +6.1% |
$71.92M +0.8% |
| R&D Expense | $7.99M -36.1% |
$12.51M -22.8% |
$16.20M -22.1% |
$20.79M -1.6% |
$21.12M +22.2% |
$17.29M +9.5% |
| Gross Profit | -$241.0K -107.5% |
$3.20M +114.3% |
$1.49M +94.8% |
$766.0K +369.9% |
$163.0K -65.0% |
$466.0K +11.2% |
- Evogene Ltd. reported Total Assets of $20.05 million for fiscal year 2025.
- Evogene Ltd. showed a decrease of -49.7% in Total Assets compared to the prior fiscal year.
- Evogene Ltd. reported R&D Expense of $7.99 million for fiscal year 2025.
- Evogene Ltd. showed a decrease of -36.1% in R&D Expense compared to the prior fiscal year.
- Evogene Ltd. reported Gross Profit of -$241.0 thousand for fiscal year 2025.
- Evogene Ltd. showed a decrease of -107.5% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: